Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2,6-diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3h-quinazolin-4-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
**Description:** 2,6-Diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3h-qunizazolin–4-one is a synthetic small molecule belonging to the quinazolinamine class of organic compounds. It has not been approved for use in any country and is classified as an experimental compound with no known clinical indications or approved therapeutic uses. There are no reported clinical trials involving this compound at any phase. Its mechanism of action and pharmacological targets have not been established in the literature or major drug databases. The molecular formula is C13H19N5OS and its average molecular weight is approximately 293.39 g/mol[1][2][3].
- Other names
- 2,6-DIAMINO-8-(2-DIMETHYLAMINOETHYLSULFANYLMETHYL)-3H-QUINAZOLIN-4-ONE2,6-diamino-8-{[2-(dimethylamino)ethyl]sulfanyl}methyl)-3,4-dihydroquinazolin-4-one2,6-diamino-8-{[2-(dimethylamino)ethyl]sulfanyl}methyl)quinazolin-4(3H)-one
Beyond the preview
Go deeper on 2,6-diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3h-quinazolin-4-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2,6-diamino-8-(2-dimethylaminoethylsulfanylmethyl)-3h-quinazolin-4-one.